In consideration of the continuing uncertainty relating to the developments of the Covid-19 pandemic, and in order to allow the meeting and the exercise of Shareholders' rights in conditions of absolute safety, the Company has decided to avail itself of the option provided for by the article 106, paragraph 4 of Legislative Decree 18 of 17 March 2020 ( “Cure Italy Decree”), as lastly amended by by Decree-Law No. 228 of 30 December 2021, converted with amendments by Law No. 15 of 25 February 2022 .

Participation in the Shareholders’ Meeting of those who are entitled to vote will take place exclusively through the shareholder representative designated by the Company pursuant to Article 135-undecies of Legislative Decree 58 of 24 February 1998 (the “Consolidated Law”) (the “Designated Representative”). The Shareholders will exercise their rights in accordance with the procedures indicated below.

In consideration of the restrictions that may be imposed for health reasons, the participation of the authorised persons in the Shareholders’ Meeting (i.e. the members of the corporate bodies, the Secretary and the Designated Representative) may also  take place using telecommunication equipment with the procedures communicated to them individually, in compliance with the regulatory provisions applicable for this eventuality.

Please note that electronic vote and/or vote by mail shall not be allowed.